Portal InstitucionalUFPEL

Objetivo Geral:

Conhecer sobre comunicação clínica e gestão da consulta;

Desenvolver as habilidades necessárias para a gestão de casos envolvendo múltiplas morbidades, múltiplos tratamentos, comunicação em consulta na forma oral e na forma escrita.

Ampliar o conhecimento dos profissionais estudantes sobre trabalho colaborativo e comunicação clínica,

Expandir o olhar do profissional médico para o cuidado longitudinal e integral dos pacientes

Programa Analítico

Unidades e Assuntos e duração

UNIDADE 1. Competências para o cuidado a grupos populacionais específicos e situações especiais: 06 horas

UNIDADE 2 - Competências de atenção à saúde para abordagem aos problemas gerais e inespecífico: 06 horas

UNIDADE 3 - Competências de atenção à saúde para abordagem aos problemas de ouvidos, nariz, garganta e pulmões: 06 horas

UNIDADE 4 - Competências de atenção à saúde para abordagem a problemas de Saúde Mental: 06 horas

UNIDADE 5 - Competências de atenção à saúde para abordagem a problemas Digestivos: 06 horas

UNIDADE 6 - Competências de atenção à saúde para abordagem a problemas Infecciosos: 06 horas

UNIDADE 7 - Como manter a cassa arrumada para uma boa comunicação: 06 horas

UNIDADE 8 - Comunicando diagnóstico: 05 horas

UNIDADE 9 - Encaminhando o paciente: 05 horas

UNIDADE 10 - Segurança do paciente: 05 horas

UNIDADE 11 - Competências de comunicação sobre prognósticos e riscos: 05 horas

UNIDADE 12 - Competências de trabalho em Equipe multiprofissional e Mediação de Conflitos de opiniões e de condutas: 05 horas

UNIDADE 13 - O cotidiano de trabalho e o projeto de intervenção: 05 horas

Atividade de Desafio Prático de Trabalho: 24 horas

Fórum do Módulo: 16 horas

Prova online e Prova Presencial Digital: 8 horas

Bibliografia Básica:

• 1. Muth C, Akker M Van Den, Blom JW, Mallen CD, Rochon J, Schellevis FG, et al. TheAriadne principles: how to handle multimorbidity in primary care consultations. BMCMed. 2014;12(223):1–11.
• 2. Eve R. PUNs and DENs: Discovering Learning Needs in General Practice. 1st editio. CRCPress; 2001.
• 3. Belzer EJ. Skills Training in Communication and Related Topics Part 2 - Communicatingwith patients, colleagues, and communities. second edi. Boca Group; 2016. 359 p.
• 4. Silverman J, Kurtz S, Draper J. Skills for Communicating with Patients. Third edit. Vol.85. Boca Raton: CRC Press; Taylor & Francis Group; 2013. 574 p.
• 5. Moulton L. The Naked Consultation: A Practical Guide to Primary Care ConsultationSkills. Second Edi. Boca Raton: CRC Press; Taylor & Francis Group; 2016. 224 p.
• 6. Neighbour R. The Inner Consultation: How to Develop an Effective and IntuitiveConsulting Style. Second edi. Boca Raton: CRC Press; Taylor & Francis Group; 2005.296 p.
• 7. Tate P, Frame F. The doctor’s communication handbook. Eighth edi. Vol. 3,Angewandte Chemie International Edition, 6(11), 951–952. Boca Raton: CRC Press;Taylor & Francis Group; 2020. 143 p.
• 8. Neighbour R. Consulting in a Nutshell: A practical guide to successful general practiceconsultations before, during and beyond the MRCGP. First edit. Boca Raton: CRCPress; Taylor & Francis Group; 2021. 213 p.
• 9. Neighbour R. The inner physician: why and how to practise ‘big picture medicine.’First edit. Boca Raton; 2016. 353 p.
• 10. Suzanne Kurtz, Jonathan Silverman JD. Teaching and Learning Communication SkillsinMedicine. Second edi. Boca Raton: CRC Press; Taylor & Francis Group; 2004. 369 p.
• 11. Cooper N, Frain J. ABC of Clinical Reasoning. Chichester: BMJ Publishing GroupLimited;2017. 66 p.
• 12. Stern S, Cifu A, Altkorn D. Symptom to Diagnosis: an Evidence Based Guide. FourthEdi.McGraw-Hill Education; 2019. 624 p.
• 13. Greenhalgh T. Uncertainty and Clinical Method. In: Sommers LS, Launer J, editors.ClinicalUncertainty in Primary Care: The Challenge of Collaborative Engagement. NewYork:Springer; 2013.
• 14. Center for Evidence-Based Medicine. Number Needed to Treat (NNT) [Internet].2021.Available from: https://www.cebm.ox.ac.uk/resources/ebm-tools/number-needed-to-treat-nnt#:~:text=Definition-,The Number Needed to Treat (NNT) is the numberof,preventone additional bad outcome.
• 15. Evidence-Based Medicine Working Group. Evidence-based medicine. A new approachtoteaching the practice of medicine. Jama The Journal Of The American MedicalAssociation.1992.
• 16. The NNT Group. The NNT home page [Internet]. 2021. Available from:https://thennt.com/
• 17. Mercer SW, Salisbury C, Fortin M. ABC of Multimorbidity. London; 2014.
• 18.Starfield B. Threads and yarns: Weaving the tapestry of comorbidity. Ann Fam Med.2006;4(2):101–3.
• 19. Islam MM, Valderas JM, Yen L, Dawda P, Jowsey T, McRae IS. Multimorbidityandcomorbidity ofchronic diseases among the senior australians: Prevalence andpatterns.PLoS One. 2014;9(1).
• 20. Valderas JM, Starfield B, Sibbald B, Salisbury C, Roland M. DefiningComorbidity:Implications for Understanding Health and Health Services. Ann FamMed.2009;7(4):357–63.
• 21. Valderas JM, Mercer SW, Fortin M. Research on patients with multiple healthconditions:different constructs, different views, one voice. 2011;1–3. Availablefrom:http://www.jcomorbidity.com/index.php/test/article/view/11/15
• 22. Violán C, Foguet-Boreu Q, Roso-Llorach A, Rodriguez-Blanco T, Pons-Vigués M, Pujol-Ribera E, et al. Burden of multimorbidity, socioeconomic status and use of healthservicesacross stages of life in urban areas: a cross-sectional study. BMC Public Health[Internet].2014;14:530. Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=4060853&tool=pmcentrez&rendertype=abstract
• 23. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiologyofmultimorbidity and implications for health care, research, and medical education: Across-sectional study. Lancet. 2012;380(9836):37–43.
• 24. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidityamongadults seen in family practice. Ann Fam Med. 2005;3(3):223–8.
• 25. Coventry P, Lovell K, Dickens C, Bower P, Chew-Graham C, McElvenny D, et al.Integratedprimary care for patients with mental and physical multimorbidity: clusterrandomisedcontrolled trial of collaborative care for patients with depressioncomorbid with diabetes orcardiovascular disease. BMJ [Internet]. 2015;350(feb163):h638–h638. Available from:http://www.bmj.com/cgi/doi/10.1136/bmj.h638
• 26. Van den Akker M, Buntix F, Metsemakers JFM, Roos S, Knottnerus JA. Multimorbidityingeneral practice: Prevalence, incidence, and determinants of co-occurring chronicandrecurrent diseases. J Clin Epidemiol. 1998;51(5):367–75.
• 27. Sinnott C, Mc Hugh S, Browne J, Bradley C. GPs’ perspectives on the management ofpatientswith multimorbidity: systematic review and synthesis of qualitative research.BMJ Open[Internet]. 2013;3(9):e003610. Availablefrom:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3773648&tool=pmcentrez&rendertype=abstract
• 28. Starfield B. Chronic Illness, Comorbidity, and Primary Care Quality [Internet].HealthSystems: Are We in a Post Reform Era? 2006. 81–84 p. Availablefrom:http://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-primary-care-policy-center/Publications_PDFs/D57.pdf
• 29. Boeckxstaens P, Vaes B, Pottelbergh G Van, Sutter A De, Dalleur O, DegryseJ.Multimorbidity measures were poor predictors of adverse events in patients aged >80 years:a prospective cohort study. J Clin Epidemiol. 2015;68:220–7.
• 30. Calderón-Larrañaga A, Gimeno-Feliu L a., González-Rubio F, Poblador-Plou B, Lairla-SanJosé M, Abad-Díez JM, et al. Polypharmacy patterns: Unravelling systematicassociationsbetween prescribed medications. PLoS One. 2013;8(12):1–10.
• 31. Calderón-Larrañaga A, Poblador-Plou B, González-Rubio F, Gimeno-Feliu LA, Abad-DíezJM, Prados-Torres A. Multimorbidity, polypharmacy, referrals, and adverse drugevents:Are we doing things well? Br J Gen Pract. 2012;62(605):821–6.
• 32. Duarte EC, Barreto SM. Transição demográfica e epidemiológica: a Epidemiologia eServiçosde Saúde revisita e atualiza o tema. Epidemiol e Serviços Saúde [Internet].2012;21(4):529–32. Available from: http://scielo.iec.pa.gov.br/scielo.php?script=sci_arttext&pid=S1679-49742012000400001&lng=en&nrm=iso&tlng=en
• 33. Abdel R. Omran. The Epidemiologic Transition: A Theory of the Epidemiology ofPopulationChange. 1971;49(4):509–38.
• 34. Marengoni A, Angleman S, Melis R, Mangialasche F, Karp A, Garmen A, et al. Agingwith multimorbidity: A systematicreview of the literature. Ageing Res Rev.2011;10(4):430–9.
• 35. Melis R, Marengoni A, Angleman S, Fratiglioni L. Incidence and predictors ofmultimorbidityin the elderly: a population-based longitudinal study. PLoS One[Internet]. 2014;9(7):e103120.Available from:http://www.scopus.com/inward/record.url?eid=2-s2.0-84904818346&partnerID=tZOtx3y1
• 36. Marengoni A, Winblad B, Karp A, Fratiglioni L. Prevalence of chronic diseasesandmultimorbidity among the elderly population in Sweden. Am J Public Health[Internet].2008;98(7):1198–200. Available from:http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2424077&tool=pmcentrez&rendertype=abstract
• 37. Marengoni A, Von Strauss E, Rizzuto D, Winblad B, Fratiglioni L. The impact ofchronicmultimorbidity and disability on functional decline and survival in elderly persons.Acommunity-based, longitudinal study. J Intern Med. 2009;265(2):288–95.
• 38. Chang JT, Morton SC, Rubenstein LZ, Mojica WA, Maglione M, Suttorp MJ, etal.Interventions for the prevention of falls in older adults: systematic review and meta-analysis of randomised clinical trials. BMJ [Internet]. 2004;328(7441):680. Available from: http://www.ncbi.nlm.nih.gov?entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=15031239
• 39. Marinho F, de Azeredo Passos VM, Carvalho Malta D, Barboza França E, AbreuDMX,Araújo VEM, et al. Burden of disease in Brazil, 1990–2016: a systematicsubnationalanalysis for the Global Burden of Disease Study 2016. Lancet [Internet].2018;392.Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673618312212
• 40. Robberstad B. QALY vs DALY vs LYs gained: What are the difference, and whatdifferencedo they make for health care priority setting? Nor Epidemiol. 2005;
• 41.Gold MR, Stevenson D, Fryback DG. HALYs and QALYs and DALYs, Oh My:Similaritiesand Differences in Summary Measures of Population Health. Annu Rev PublicHealth.2002;
• 42. Reidpath DD, Allotey PA, Kouame AKA, Cummins RA. Measuring health in avacuum:examining the disability weight of the DALY. 2003;18(4):351–6.
• 43. May C, Montori VM, Mair FS. We need minimally disruptive medicine.BMJ.2009;339(august):b2803.
• 44. Choosing wisely Canada. Thirteen Things Physicians and Patients Should Question[Internet].2018 [cited 2020 Apr 25]. Available from:https://choosingwiselycanada.org/family-medicine/
• 45. Levinson W, Kallewaard M, Bhatia RS, Wolfson D, Shortt S, Kerr EA. ‘Choosing Wisely’:agrowing international campaign. BMJ. 2014;(December):1–9.
• 46. Gérvas J, Pérez-Fernández M. Sano Y Salvo: (y libre de intervenciones médicasinnecesarias).1a edição. Malpaso Editorial; 2021.
• 47. Mangin D, Heath I. Multimorbidity and Quaternary Prevention (P4). Rev Bras MedFamília eComunidade [Internet]. 2015;10(35):1. Availablefrom:http://www.rbmfc.org.br/rbmfc/article/view/1069
• 48. Jamoulle M. Quaternary prevention, an answer of family doctors toovermedicalization. Int JHeal Policy Manag [Internet]. 2015;4(2):61–4. Availablefrom:http://ijhpm.com/article_2950_0.html
• 49. Norman AH, Tesser CD. Prevenção quaternária: as bases para sua operacionalizaçãonarelação médico-paciente. Rev Bras Med Família e Comunidade. 2015;10(35):1–10.
• 50. Moynihan R, Heath I, Henry D. Selling sickness: the pharmaceutical industry anddiseasemongering. BMJ. 2002;324(7342):886–91. Raton: CRC Press; Taylor & Francis

Bibliografia Complementar:

• 10. Suzanne Kurtz, Jonathan Silverman JD. Teaching and Learning Communication Skills inMedicine. Second edi. Boca Raton: CRC Press; Taylor & Francis Group; 2004. 369 p.
• 11. Cooper N, Frain J. ABC of Clinical Reasoning. Chichester: BMJ Publishing GroupLimited; 2017. 66 p.